$213 | SAVE $37 | Single User
$425 | SAVE $75 | Site License
$638 | SAVE $112 | Enterprise License

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile.
[Report Updated: 20-07-2017]

Published by Global Data: 20 Jul 2017 | 106766 | In Stock
Related Topics: Drug Discovery , Healthcare

Introduction

Summary

Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation that offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. The foundation offers services and support for development of drugs to prevent, treat, and cure Alzheimer’s disease. It offers grants to the recipients for the treatment of Alzheimer’s disease. The foundation offers funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

    Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10

    Venture Financing 10

    M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 10

    Partnerships 11

    Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 11

    Equity Offering 11

    Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 11

    Alzheimer's Drug Discovery Foundation - Key Competitors 13

    Key Employees 14

    Locations And Subsidiaries 15

    Head Office 15

    Recent Developments 16

    Government and Public Interest 16

    Mar 01, 2017: Cypralis Announces Grant Award from Alzheimer’s Drug Discovery Foundation 16

    Product News 17

    Jun 07, 2017: The Alzheimer's Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 17

    Appendix 18

    Methodology 18

    About GlobalData 18

    Contact Us 18

    Disclaimer 18

List Of Tables
in Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017]

List of Tables

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts 1

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Alzheimer's Drug Discovery Foundation, Deals By Therapy Area, 2011 to YTD 2017 8

Alzheimer's Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 10

Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimer's Disease Drugs 11

Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 11

Alzheimer's Drug Discovery Foundation, Key Competitors 13

Alzheimer's Drug Discovery Foundation, Key Employees 14

Additional Details

Publisher

Global Data

Publisher Information

Reference

106766 | GDPH213658D

Number of Pages

18

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Global Alzheimers Drug Market Research Report Forecast 2017 to 2021
The Global Alzheimers Drug Market Research Report Forecast 2017-2021 is a valuable source of insight...
13 Nov 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Global Alzheimers Drug Market Research Report Forecast 2017 to 2021
The Global Alzheimers Drug Market Research Report Forecast 2017-2021 is a valuable source of insight...
13 May 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile. [Report Updated: 20-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...